Crystalline nephropathy due to 2,8-dihydroxyadeninuria: an under-recognized cause of irreversible renal failure
- PMID: 20064951
- DOI: 10.1093/ndt/gfp711
Crystalline nephropathy due to 2,8-dihydroxyadeninuria: an under-recognized cause of irreversible renal failure
Abstract
Background: 2,8-dihydroxyadeninuria (DHA) disease (also called 2,8 dihydroxyadeninuria) is a rare autosomal recessive disorder caused by complete adenine phosphoribosyltransferase deficiency and typically manifests as recurrent nephrolithiasis. Only rare cases of DHA nephrolithiasis have been reported from the USA. Herein, we report three American patients who developed DHA crystalline nephropathy leading to end-stage renal disease (ESRD) with recurrence in the allograft.
Methods: Three cases of DHA crystalline nephropathy were identified from the Renal Pathology Laboratory of Mayo Clinic. Detailed clinical and pathologic descriptions are provided.
Results: All three patients were Caucasian adults with no history of obstructive nephropathy. Two patients had no history of nephrolithiasis and one had a single episode of stones 36 years prior to presentation. All patients presented with severe renal failure with a mean serum creatinine of 7.5 mg/dl. Renal biopsies revealed numerous tubular and interstitial brown DHA crystals, tubular degenerative changes and moderate to marked tubulointerstitial scarring. Two patients were initially misdiagnosed, one as primary hyperoxaluria and the other as chronic interstitial nephritis. All three patients progressed to ESRD, within 1 month following renal biopsy in two and after 9 months in one. All three patients underwent renal transplantation with early disease recurrence in three allografts in two patients.
Conclusions: DHA disease is an under-recognized condition that can lead to irreversible renal failure and frequently recurs in the transplant. It should be included in the differential diagnosis of crystalline nephropathy, even in the absence of history of nephrolithiasis.
Comment in
-
Acquired DHA nephropathy in rats.Nephrol Dial Transplant. 2010 Oct;25(10):3455-6; author reply 3456. doi: 10.1093/ndt/gfq390. Epub 2010 Jul 7. Nephrol Dial Transplant. 2010. PMID: 20610528 No abstract available.
Similar articles
-
[A case of adenine phosphoribosyltransferase (APRT) deficiency discovered by urine examination].Nihon Jinzo Gakkai Shi. 1994 Oct;36(10):1191-5. Nihon Jinzo Gakkai Shi. 1994. PMID: 7815752 Review. Japanese.
-
[Acute renal failure and 2,8-dihydroxyadeninuria].Nephrologie. 2004;25(7):297-300. Nephrologie. 2004. PMID: 15584640 French.
-
[2,8-Dihydroxyadeninuria: 2.8-dihydroxyadenine crystals in urinary sediment in patients with adenine-phosphoribosyltransferase deficiency].Dtsch Med Wochenschr. 1982 Dec 10;107(49):1887-90. doi: 10.1055/s-2008-1070226. Dtsch Med Wochenschr. 1982. PMID: 7140571 German.
-
2,8-dihydroxyadeninuria: are there no cases in Scandinavia?Scand J Urol Nephrol. 2005;39(1):82-6. doi: 10.1080/00365590510007621. Scand J Urol Nephrol. 2005. PMID: 15764278
-
2,8-dihydroxyadenine urolithiasis: report of a case first diagnosed after renal transplant.Q J Med. 1988 Oct;68(258):785-93. Q J Med. 1988. PMID: 3077470 Review.
Cited by
-
Adenine phosphoribosyltransferase deficiency in the United Kingdom: two novel mutations and a cross-sectional survey.Clin Kidney J. 2016 Dec;9(6):800-806. doi: 10.1093/ckj/sfw093. Epub 2016 Oct 3. Clin Kidney J. 2016. PMID: 27994857 Free PMC article.
-
Primary disease recurrence—effects on paediatric renal transplantation outcomes.Nat Rev Nephrol. 2015 Jun;11(6):371-84. doi: 10.1038/nrneph.2015.54. Epub 2015 Apr 28. Nat Rev Nephrol. 2015. PMID: 25917555 Review.
-
A Rare Genetic Mutation in a Stone Former.Indian J Nephrol. 2021 Mar-Apr;31(2):197-200. doi: 10.4103/ijn.IJN_366_19. Epub 2021 Apr 2. Indian J Nephrol. 2021. PMID: 34267448 Free PMC article.
-
Do kidney stone formers have a kidney disease?Kidney Int. 2015 Dec;88(6):1240-1249. doi: 10.1038/ki.2015.254. Epub 2015 Sep 16. Kidney Int. 2015. PMID: 26376133 Free PMC article. Review.
-
Detection and localization of calcium oxalate in kidney using synchrotron deep ultraviolet fluorescence microscopy.J Synchrotron Radiat. 2022 Jan 1;29(Pt 1):214-223. doi: 10.1107/S1600577521011371. Epub 2022 Jan 1. J Synchrotron Radiat. 2022. PMID: 34985438 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical